≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Pulmonary eosinophilia, not elsewhere classified

DOID EFO Endpoint Browser PheWeb

J10_PULMEOS

eosinophilic pneumonia: An inflammatory lung disorder characterized by an increased number of eosinophils in the lungs. The majority of cases are idiopathic, without identifiable cause. In a minority of cases, medications, fungal infections, and environmental triggers have been implicated. It manifests as acute or chronic. Acute eosinophilic pneumonia is a severe and rapidly progressing pneumonia that may lead to respiratory failure requiring mechanical ventilation. Chronic eosinophilic pneumonia follows a slower course and manifests as fever, dyspnea, cough, and weight loss.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J82
  • Hospital discharge: ICD-9 — 5183
  • Hospital discharge: ICD-8 — 51920
  • Cause of death: ICD-10 — J82
  • Cause of death: ICD-9 — 5183
  • Cause of death: ICD-8 — 51920

2 out of 7 registries used, show all original rules.

426

4. Check minimum number of events

None

426

5. Include endpoints

None

426

6. Filter based on genotype QC (FinnGen only)

426

Control definitions (FinnGen only)

Control exclude
J10_INTERSTITIUM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J80-J84
Name in latin
Eosinophilia pulmonum non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3168 1780 1353
Only index persons 2462 1464 998
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.04
Only index persons 0.05 0.05 0.04
Median age at first event (years)
Whole population 59.21 58.03 60.60
Only index persons 56.56 55.95 57.46

-FinnGen-

Key figures

All Female Male
Number of individuals 426 241 185
Unadjusted period prevalence (%) 0.08 0.08 0.08
Median age at first event (years) 57.08 54.05 61.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
393
Matched controls
3929
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
+∞
323.0
344
*
H02AB06
ATC
prednisolone; systemic
14.1
96.5
348
1390
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.3
72.8
138
153
J18.9
ICD-10 Finland
Pneumonia, unspecified
7.0
66.7
224
627
TGC00
NOMESCO Finland
Bronchial lavation
31.6
66.6
89
36
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
6.5
58.4
193
505
J45.0
ICD-10 Finland
Predominantly allergic asthma
10.4
55.3
118
156
J45.9
ICD-10 Finland
Asthma, unspecified
6.3
53.0
176
450
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
14.5
51.1
90
79
J45.1
ICD-10 Finland
Nonallergic asthma
10.0
50.8
110
147
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.9
50.8
131
234
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
+∞
47.9
45
*
5183A
ICD-9 Finland
Other diseases of lung, Pulmonary eosinophilia
+∞
40.3
38
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.2
39.1
231
998
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.9
37.9
86
120
R03DC03
ATC
montelukast; oral
5.2
36.1
131
344
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
36.0
34
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.4
34.7
101
202
J01MA14
ATC
moxifloxacin; systemic
6.5
34.5
98
190
R03AC02
ATC
salbutamol; inhalant
3.8
33.7
276
1498
R03BA02
ATC
budesonide; inhalant
4.3
30.3
133
414
D72.1
ICD-10 Finland
Eosinophilia
54.7
29.9
35
7
51920
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis eosinophilica
+∞
29.5
28
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.6
28.8
116
330
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.5
27.5
58
70
M05BA04
ATC
alendronic acid; oral
5.3
26.0
86
196
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
+∞
24.2
23
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
24.2
236
1306
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
11.4
22.7
43
42
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.7
22.3
46
53
R03BA01
ATC
beclometasone; inhalant
3.9
21.9
104
335
J01FA06
ATC
roxithromycin; oral
2.8
21.5
209
1120
R03BA05
ATC
fluticasone; inhalant
3.5
21.3
116
415
L04AX01
ATC
azathioprine; systemic
8.0
21.1
49
69
R03AK08
ATC
formoterol and beclometasone; inhalant
7.0
20.1
51
82
R03DA04
ATC
theophylline; systemic, rectal
5.6
19.9
61
125
R03BA08
ATC
ciclesonide; inhalant
4.9
19.8
69
164
R03AC13
ATC
formoterol; inhalant
5.8
19.8
58
113
J46
ICD-10 Finland
Status asthmaticus
9.2
19.5
41
49
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.9
19.4
45
63
H02AB04
ATC
methylprednisolone; systemic
3.5
19.4
105
372
J33.0
ICD-10 Finland
Polyp of nasal cavity
9.0
19.2
41
50
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.2
19.0
53
97
J33.8
ICD-10 Finland
Other polyp of sinus
13.2
19.0
33
27
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
5.9
18.6
54
104
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
46.4
18.4
22
5
H02AB07
ATC
prednisone; oral
3.4
17.9
98
349
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.9
17.8
61
142
R03BB04
ATC
tiotropium bromide; inhalant
3.9
17.8
81
248
XG410
NOMESCO Finland
Flow-volume spirometry
6.8
17.6
45
73
J01MA12
ATC
levofloxacin; systemic
3.0
17.4
119
493
49300
ICD-8 Finland
Asthma, bronchiale
11.1
17.0
32
31
R03AC12
ATC
salmeterol; inhalant
6.1
16.6
46
83
A02BC02
ATC
pantoprazole; systemic
2.6
16.3
295
2102
J45.8
ICD-10 Finland
Mixed asthma
7.7
16.0
37
52
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
15.7
15
*
R03AK07
ATC
formoterol and budesonide; inhalant
2.9
15.4
111
472
R01AD09
ATC
mometasone; nasal
2.3
14.7
201
1212
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
7.6
14.6
34
48
R01AD08
ATC
fluticasone; nasal
2.5
14.3
137
685
R01AD05
ATC
budesonide; nasal
4.0
14.2
59
165
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
14.1
216
1365
J32.4
ICD-10 Finland
Chronic pansinusitis
14.3
13.9
23
17
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.1
13.7
44
95
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
7.6
13.3
31
44
J47
ICD-10 Finland
Bronchiectasis
9.3
13.2
27
31
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.5
13.1
47
114
J01FA10
ATC
azithromycin; systemic
2.1
12.0
233
1590
M81.4
ICD-10 Finland
Drug-induced osteoporosis
23.7
11.7
16
7
DHB20
NOMESCO Finland
Polypectomy of internal nose
12.3
11.5
20
17
J01FA09
ATC
clarithromycin; systemic
2.2
11.3
142
793
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
25.9
11.2
15
6
J01AA02
ATC
doxycycline; systemic
2.3
10.8
320
2562
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.9
10.4
25
38
R03AC03
ATC
terbutaline; inhalant
2.7
10.3
78
334
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.4
10.2
99
486
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.0
10.1
24
36
J31.0
ICD-10 Finland
Chronic rhinitis
3.6
10.0
45
135
R06.0
ICD-10 Finland
Dyspnoea
2.2
9.6
120
661
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
9.6
105
543
J01FA15
ATC
telithromycin; oral
3.0
9.6
56
205
R03DC01
ATC
zafirlukast; oral
8.4
9.5
20
25
5BA08
NOMESCO Finland
NA
102.4
9.5
10
*
L04AA06
ATC
mycophenolic acid; systemic
9.9
9.4
18
19
R03AK11
ATC
formoterol and fluticasone; inhalant
6.4
9.1
23
38
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
24.7
9.0
12
5
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
8.9
32
79
M05BB03
ATC
alendronic acid and colecalciferol; oral
6.4
8.7
22
36
R01AD01
ATC
beclometasone; nasal
2.4
8.7
77
358
J01DA06
ATC
[U] cefuroxime; systemic
2.5
8.7
69
303
M05BA07
ATC
risedronic acid; oral
4.6
8.6
29
67
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
20.6
8.5
12
6
R96
ICPC
Asthma
2.9
8.5
52
194
WW200
NOMESCO Finland
Immunization
6.3
8.3
21
35
R06AE07
ATC
cetirizine; oral
1.9
8.3
173
1153
R03BB01
ATC
ipratropium bromide; inhalant
4.1
8.3
31
80
DPA30
NOMESCO Finland
Sphenotomy
14.9
8.3
13
9
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
8.0
85
429
J45
ICD-10 Finland
Asthma
2.7
7.8
55
224
ZX120
NOMESCO Finland
Intravenous
2.8
7.8
52
206
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
45.9
7.7
9
*
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
18.8
7.6
11
6
R01AD12
ATC
fluticasone furoate; nasal
2.0
7.6
113
659
R05
ICD-10 Finland
Cough
2.1
7.6
90
477
XQ800
NOMESCO Finland
Prick test
3.3
7.5
37
121
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
7.4
46
174
J01CA04
ATC
amoxicillin; systemic
2.0
7.4
311
2584
R06AX27
ATC
desloratadine; oral
2.0
7.4
103
585
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
7.3
7
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
12.3
7.1
12
10
R01BA52
ATC
pseudoephedrine, combinations; oral
1.9
7.0
127
792
R81
ICPC
Pneumonia
4.2
7.0
25
62
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.9
7.0
27
72
A02BC01
ATC
omeprazole; systemic
1.9
7.0
127
795
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
40.8
6.8
8
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
40.8
6.8
8
*
J02AC03
ATC
voriconazole; systemic
40.8
6.8
8
*
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
23.0
6.7
9
*
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
23.0
6.7
9
*
1240
FHL
Bronchoscopy
6.1
6.7
17
29
ZXA10
NOMESCO Finland
Bilateral
2.0
6.6
89
496
J01MA02
ATC
ciprofloxacin; systemic
1.8
6.6
165
1141
A02BC05
ATC
esomeprazole; systemic
1.8
6.5
163
1130
R06.2
ICD-10 Finland
Wheezing
3.4
6.3
29
90
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
18.4
6.3
9
5
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.4
6.2
54
249
P01BA02
ATC
hydroxychloroquine; oral
2.6
6.2
43
176
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
8.8
6.1
12
14
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
6.2
6.1
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009445) Proteinase 3 Ab [Units/volume] in Serum
114
116
13.05
104.43
2.6
1.3
u/ml
6.5
—
—
10
0
(3005322) IgE [Units/volume] in Serum or Plasma
113
190
7.73
68.26
2.6
1.2
u/ml
400.1
193.1
1.39
106
171
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
73
103
8.35
50.80
2.8
2.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
40
13.40
48.75
2.0
1.9
g/l
1.7
0.9
0.86
38
34
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
37
19
21.23
48.11
1.9
1.1
u/ml
5.3
0.1
—
28
9
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
58
75
8.79
43.17
1.5
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
241
1083
3.82
41.15
11.1
5.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
316
1735
4.18
39.16
14.0
5.5
e9/l
0.3
0.2
20.17
303
1522
(3001604) Monocytes [#/volume] in Blood
308
1667
4.06
38.87
12.7
5.3
e9/l
0.7
0.6
6.57
292
1436
(3022096) Basophils/100 leukocytes in Blood
291
1521
3.88
38.62
12.9
5.4
%
0.8
0.7
2.57
286
1408
(3006315) Basophils [#/volume] in Blood
308
1682
4.00
37.99
12.7
5.3
e9/l
0.1
0.0
6.53
293
1454
(3019198) Lymphocytes [#/volume] in Blood
310
1706
4.00
37.66
12.9
5.4
e9/l
1.9
1.9
0.39
295
1505
(3006504) Eosinophils/100 leukocytes in Blood
293
1568
3.78
36.82
13.0
5.4
%
4.4
2.8
10.78
288
1444
(3018010) Neutrophils/100 leukocytes in Blood
294
1581
3.77
36.57
12.4
5.3
%
59.0
57.3
1.80
287
1469
(3019069) Monocytes/100 leukocytes in Blood
293
1576
3.75
36.35
13.4
5.7
%
8.6
8.7
0.41
288
1467
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
45
53
9.38
35.89
1.5
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
40
41
10.66
35.29
3.2
2.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
293
1602
3.66
34.85
13.2
5.5
%
24.5
27.6
5.72
288
1479
(3028192) IgG subclass 2 [Mass/volume] in Serum
31
25
13.29
31.83
1.8
1.3
g/l
3.4
2.9
0.53
24
20
(3024139) IgG subclass 3 [Mass/volume] in Serum
31
25
13.29
31.83
1.8
1.3
g/l
0.3
0.4
0.18
25
20
(3027135) IgG subclass 1 [Mass/volume] in Serum
31
25
13.29
31.83
1.8
1.3
g/l
6.5
6.7
0.09
25
20
(3013650) Neutrophils [#/volume] in Blood by Automated count
321
1946
3.64
30.56
14.9
8.8
e9/l
5.0
4.0
6.02
306
1701
(4062490)
30
27
11.88
28.75
1.9
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
27
23
12.47
26.74
2.1
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
53
7.55
24.99
1.9
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
43
7.97
22.79
1.9
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
107
401
3.23
22.20
1.5
1.3
titre
805.3
541.2
0.54
15
98
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
54
6.97
22.08
2.2
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
11
17.04
21.23
1.6
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
40
76
5.70
20.55
2.2
1.6
—
—
—
0
0
(3000492) Spirometry study
86
296
3.39
20.38
2.6
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
73
5.78
20.35
2.3
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
76
246
3.54
19.79
5.4
4.1
%
0.5
0.5
0.02
26
59
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
28
39
7.61
19.30
4.2
3.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
81
284
3.29
18.54
5.8
4.2
%
0.7
1.0
0.62
31
90
(3021440) Promyelocytes/100 leukocytes in Blood
77
265
3.33
18.14
5.9
4.3
%
0.1
0.2
0.64
29
78
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
231
1392
2.44
18.09
3.0
2.2
nmol/l
84.1
78.2
2.04
222
1219
(3021589) Normoblasts [#/volume] in Blood
241
1482
2.44
18.01
15.3
9.3
e9/l
0.0
0.0
0.29
214
1214
(3025159) Blasts/100 leukocytes in Blood
74
255
3.30
17.36
5.8
4.3
%
0.0
0.2
0.66
27
66
(4010399)
73
250
3.32
17.30
2.1
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
41
6.96
17.23
1.9
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
35
7.53
17.13
1.9
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
22
9.49
16.55
1.2
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
82
311
3.03
16.32
2.3
2.0
nmol/l
316.8
370.4
0.49
76
277
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
22
28
8.23
16.30
2.4
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
62
199
3.48
16.24
1.9
1.7
g/l
1.1
1.6
0.80
62
177
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
48
6.17
15.92
1.9
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
184
1051
2.32
15.68
4.9
3.8
ph
7.4
7.4
0.05
35
198
(46235355) HIV 1 and 2 tests - Meaningful Use set
94
394
2.78
15.53
1.6
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
112
520
2.57
15.05
2.9
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
97
420
2.70
15.01
2.5
1.4
—
—
—
0
0
(44790047)
23
34
7.09
15.00
2.1
1.4
—
—
—
0
0
(44806118)
23
34
7.09
15.00
2.1
1.4
—
—
—
0
0
(44790048)
23
34
7.09
15.00
2.1
1.4
—
—
—
0
0
(44790049)
23
34
7.09
15.00
2.1
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
32
7.19
14.55
2.4
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
103
4.18
14.31
1.5
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
45
5.84
13.52
2.6
3.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
17
20
8.81
13.33
2.5
1.6
e9/l
1.3
1.0
—
9
8
(40758558) Short blood count panel - Blood
153
859
2.22
13.10
10.1
6.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
47
5.59
12.92
1.8
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
333
2545
2.41
12.86
8.8
4.1
mm/h
14.7
12.5
2.16
325
2340
(40760892) CBC W Ordered Manual Differential panel - Blood
134
720
2.26
12.71
10.3
4.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
48
5.47
12.64
11.2
4.6
iu/ml
170.8
139.8
—
5
5
(3003327) Ova and parasites identified in Stool by Light microscopy
35
91
4.10
12.35
2.0
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
39
110
3.80
12.31
1.2
1.2
u/ml
0.4
0.2
—
6
10
(3023368) Bacteria identified in Blood by Culture
166
982
2.13
12.30
5.3
4.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
42
5.73
12.25
1.1
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
87
393
2.53
12.17
2.2
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
252
1746
2.09
12.15
8.9
6.0
mmol/l
1.2
1.2
0.21
226
1476
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
29
66
4.64
12.10
1.0
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
114
584
2.30
12.04
2.5
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
55
4.97
11.81
6.5
3.8
%
57.0
58.8
0.21
26
55
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
15
5
31.00
11.72
1.6
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
232
1601
1.99
10.84
7.4
5.4
mmol/l
1.2
1.2
0.03
221
1442
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
87
414
2.38
10.78
2.2
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
337
2679
2.23
10.42
11.4
7.3
u/l
75.6
79.8
1.31
325
2493
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
16
24
6.89
10.25
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
10
11.27
10.20
2.8
7.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
86
418
2.32
10.12
2.3
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
60
248
2.65
9.98
1.7
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
15
9
17.21
9.94
3.6
1.3
ug/l
39.7
87.8
—
15
9
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
306
2.50
9.93
1.4
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
15
22
7.03
9.79
2.2
2.0
e6/l
754.6
460.0
—
8
7
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
257
1882
1.92
9.61
6.8
5.9
umol/l
10.6
11.2
0.71
249
1777
(3028433) Virus identified in Specimen by Culture
12
14
8.79
9.39
1.4
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
84
418
2.26
9.31
7.9
4.5
mmol/l
1.0
1.0
0.07
79
376
(3006184) Hemoglobin [Mass/volume] in Capillary blood
26
67
4.07
9.28
1.4
2.0
g/l
121.4
128.4
0.55
16
51
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
185
2.80
9.12
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
12
9.38
9.01
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
109
610
2.06
8.93
1.7
1.4
g/l
2.4
2.5
0.15
79
345
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
10
10.22
8.67
2.0
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
10
10.22
8.67
2.0
1.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
100
549
2.07
8.59
3.0
2.2
umol/l
13.2
12.9
0.13
92
500
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
96
3.40
8.52
1.6
1.6
iu/ml
1.3
0.0
—
8
15
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
13
8.66
8.50
1.6
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
71
342
2.29
8.46
1.4
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
11
9.29
8.11
2.1
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
118
703
1.94
8.00
3.1
2.9
mosm/kgh2o
503.2
553.0
2.16
108
601
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
31
5.32
7.99
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
31
5.32
7.99
2.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
31
5.32
7.99
2.1
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
123
750
1.90
7.74
2.0
1.7
mg/l
1.0
1.1
0.33
95
588
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
36
4.88
7.70
1.3
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
15
7.50
7.58
1.6
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
69
3.63
7.38
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
134
855
1.83
7.25
2.7
2.1
mg/l
3.2
3.2
0.02
119
728
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
34
4.85
7.22
1.2
1.1
u/ml
0.2
2.0
—
7
11
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
208
2.47
7.22
4.3
2.8
mmol/l
1.6
1.9
0.18
37
152
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
16
7.03
7.18
1.6
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
62
305
2.21
6.99
3.2
3.1
ng/l
239.4
207.1
0.19
56
280
(3004789) Transferrin [Mass/volume] in Serum or Plasma
88
500
1.96
6.75
3.0
2.2
g/l
2.3
2.3
0.48
81
458
(3013826) Glucose [Moles/volume] in Serum or Plasma
263
2071
1.71
6.50
6.0
4.5
mmol/l
6.7
6.7
0.02
253
1943
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
476
1.95
6.48
3.2
2.2
%
23.1
22.4
0.18
74
404
(3030467) Casts [#/volume] in Urine by Automated count
143
960
1.74
6.37
4.0
3.0
e6/l
0.3
0.5
1.06
116
709
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
47
3.95
6.32
1.2
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
48
221
2.32
6.32
4.4
2.7
ph
7.4
7.4
—
7
24
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
176
1253
1.69
6.31
4.8
3.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
53
255
2.23
6.30
3.6
3.2
ng/l
91.1
79.3
0.46
44
222
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
39
4.22
6.14
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
74
3.23
5.98
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
74
3.23
5.98
1.3
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.38
5.98
2.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.38
5.98
2.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.38
5.98
2.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.38
5.98
2.0
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
158
1106
1.68
5.97
3.9
3.2
u/l
27.5
31.9
2.63
151
1051
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
69
3.31
5.95
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
110
700
1.77
5.84
4.2
3.9
ng/l
194.1
234.2
0.16
95
570
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
20
5.62
5.83
1.6
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
9
11.34
5.82
1.5
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
112
723
1.74
5.64
3.3
2.5
e6/l
3.8
5.0
0.67
104
646
(3002582) Erythrocytes [#/volume] in Urine
150
1054
1.65
5.49
4.2
3.2
e6/l
87.4
129.3
0.18
125
808
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
92
565
1.80
5.48
1.4
1.3
iu/ml
18.7
36.5
2.12
27
185
(3022313) Gas panel - Capillary blood
37
162
2.41
5.46
4.8
2.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
5
16.26
5.43
1.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
196
1481
1.60
5.30
12.1
8.9
inr
1.2
1.2
0.13
58
415
(36304419) Bacteria [Presence] in Urine
135
931
1.66
5.28
4.1
2.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
184
1378
1.59
5.11
3.2
2.6
ug/l
134.2
131.2
0.06
169
1255
(3024561) Albumin [Mass/volume] in Serum or Plasma
200
1529
1.58
5.08
7.3
4.2
g/l
33.8
35.3
3.28
189
1423
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
87
537
1.78
5.07
1.4
1.3
u/ml
12.2
12.3
0.00
29
209
(3008536) Aspergillus sp Ab [Presence] in Serum
9
9
10.18
5.05
2.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
49
252
2.07
4.93
1.3
2.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
67
3.08
4.89
2.1
2.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
7
11.61
4.80
3.1
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
233
1861
1.56
4.78
3.3
2.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
165
1226
1.56
4.63
4.9
3.7
e6/l
311.2
83.0
0.39
131
870
(3019060) Gas panel - Arterial blood
48
251
2.03
4.62
5.3
6.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
39
3.68
4.52
6.6
4.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
162
1207
1.55
4.46
4.6
3.2
mmol/l
2.3
2.4
0.24
148
1054
(3003396) Base excess in Arterial blood by calculation
68
405
1.81
4.45
6.9
7.0
mmol/l
1.7
1.3
0.38
55
327
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
84
2.71
4.30
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
67
2.92
4.28
2.2
2.2
%
14.6
15.4
0.33
12
31
(3012095) Magnesium [Moles/volume] in Serum or Plasma
84
539
1.70
4.24
5.3
3.3
mmol/l
0.8
0.8
0.25
79
497
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
36
3.69
4.23
1.2
1.0
u/ml
0.6
3.0
—
6
12
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
27
4.16
4.18
1.7
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
99
2.51
4.04
3.1
2.2
u/ml
0.3
0.4
0.86
17
58
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
28
4.01
4.00
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
48
3.20
3.96
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
76
2.71
3.95
4.7
3.8
mmol/l
4.3
2.9
0.64
14
49
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
12
33
3.71
3.95
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
29
3.87
3.82
1.8
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
29
3.87
3.82
1.8
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
189
2.05
3.81
2.3
2.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
72
2.72
3.78
3.8
3.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
21
84
2.58
3.77
2.1
2.0
kpa
8.7
7.8
1.03
21
74
(3025941) Bacteria identified in Stool by Culture
35
179
2.04
3.60
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
47
267
1.85
3.58
5.2
6.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
26
3.91
3.54
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
26
3.91
3.54
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
26
3.91
3.54
1.1
1.1
—
—
—
0
0
(4306422)
12
36
3.40
3.50
1.3
1.3
—
—
—
0
0
(3012544) pH of Venous blood
55
332
1.75
3.44
6.2
3.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
65
413
1.68
3.39
3.2
2.5
%
1.8
1.8
0.17
59
366
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
27
3.77
3.37
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
27
3.77
3.37
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
27
3.77
3.37
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
27
3.77
3.37
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
147
1126
1.47
3.36
4.9
3.1
ng/l
1669.0
1378.2
0.42
136
960
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
32
3.50
3.35
1.2
1.0
u/ml
0.5
1.0
—
6
9
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
77
2.54
3.34
1.2
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
53
321
1.74
3.28
6.1
3.0
mmol/l
3.1
2.2
0.50
43
257
(36660697) Celiac disease serology panel - Serum
40
224
1.87
3.20
1.4
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
22
98
2.31
3.18
2.0
2.2
mmol/l
23.9
24.9
0.47
22
81
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
13
44
3.02
3.16
1.2
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
146
2.06
3.13
2.5
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
273
2365
1.43
3.09
6.5
4.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
5
10.10
2.98
1.2
1.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
25
122
2.11
2.93
2.7
2.2
ug/l
138.5
321.8
1.59
25
114
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
367
3385
1.61
2.91
29.0
14.5
mg/l
22.5
24.0
0.45
342
2690
(3029075) Extractable nuclear Ab panel - Serum
7
13
5.45
2.88
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
13
5.45
2.88
1.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
79
548
1.54
2.88
3.5
2.9
e6/l
0.8
2.3
2.98
49
284
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
9
6.74
2.87
1.2
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
171
1378
1.40
2.87
2.2
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
47
2.82
2.84
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
18
4.51
2.80
1.0
1.3
—
—
—
0
0
(3010421) pH of Blood
20
91
2.26
2.78
4.7
3.6
ph
7.4
7.4
1.16
20
74
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
24
118
2.10
2.77
1.2
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
42
2.91
2.77
1.2
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
6
8.41
2.75
1.4
1.7
—
—
—
0
0
(44813793)
7
14
5.06
2.74
1.1
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
37
3.03
2.71
1.5
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
10
6.07
2.70
1.2
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
574
1.51
2.67
3.3
2.7
e6/l
0.5
1.1
2.20
51
307
(21494434) Karyotype in Bone marrow
10
32
3.18
2.66
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
224
1.76
2.61
3.1
2.8
e9/l
5.4
3.9
2.36
31
167
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
138
1087
1.40
2.60
2.7
2.0
u/l
105.5
226.7
4.19
132
1026
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
139
1098
1.39
2.57
2.8
2.4
u/l
54.0
57.4
0.69
133
1013
(3026493) Urate [Moles/volume] in Serum or Plasma
117
897
1.42
2.57
4.1
2.5
umol/l
12798.9
7735.5
0.27
107
760
(4015189)
5
7
7.21
2.55
5.8
3.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
7
7.21
2.55
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
135
1064
1.39
2.53
4.0
3.0
mmol/l
6.8
7.2
0.63
116
861
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
144
1.93
2.52
1.2
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
144
1.93
2.52
1.2
2.0
g/l
3.8
3.8
0.06
22
103
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
8
6.31
2.38
2.0
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
47
2.60
2.29
1.2
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
107
2.01
2.24
1.6
1.4
ug/g
243.4
294.5
—
10
61
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.61
2.22
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
9
5.61
2.22
1.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
17
80
2.17
2.21
1.1
1.1
—
50.0
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
48
2.54
2.20
1.3
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
42
2.66
2.20
1.5
1.7
pg
30.9
33.1
0.75
11
42
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
137
1.88
2.18
2.2
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
19
3.73
2.16
1.3
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
45
294
1.59
2.14
2.8
2.5
e9/l
76.1
66.8
0.77
34
228
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
10
5.04
2.07
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
56
2.36
2.06
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
76
2.15
2.05
2.0
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
90
685
1.40
2.04
1.4
1.2
u/ml
0.6
1.5
1.66
17
182
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
98
1.98
1.98
1.4
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
135
1103
1.33
1.94
3.9
3.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
27
3.00
1.94
1.3
2.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
27
3.00
1.94
2.1
2.9
%
13.8
13.2
—
8
27
(3048689) Calprotectin [Mass/mass] in Stool
52
360
1.51
1.93
2.9
2.2
ug/g
134.5
143.1
0.08
43
280
(3012516) Albumin [Mass/volume] in Urine
127
1030
1.33
1.92
4.0
3.1
mg/l
429.8
221.3
0.21
83
643
(40768443) Skin Pathology biopsy report
27
159
1.75
1.90
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
41
270
1.57
1.90
4.2
4.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
56
396
1.48
1.88
2.4
2.7
umol/l
5.8
8.7
1.54
49
349
(3045142) Bone marrow Pathology biopsy report
9
35
2.60
1.81
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
100
790
1.35
1.80
4.8
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
194
1681
1.28
1.77
4.7
3.8
estimate
0.0
0.0
0.00
46
322
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
171
1.68
1.75
10.6
9.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
18
3.37
1.75
1.0
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
18
3.37
1.75
1.0
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
13
3.88
1.72
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
25
149
1.72
1.71
5.8
4.3
—
—
—
0
0
(3044889) 12 lead EKG panel
269
2435
1.28
1.71
4.4
4.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
194
1688
1.27
1.69
6.5
5.1
estimate
0.0
0.0
0.00
44
317
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
42
2.41
1.69
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
42
2.41
1.69
2.0
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
42
2.41
1.69
2.0
1.8
%
89.0
90.4
—
10
42
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
169
1447
1.28
1.68
5.2
3.8
ng/l
29.4
60.9
0.73
125
1056
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
16
83
1.96
1.66
2.6
2.3
mg/l
1.7
1.6
0.09
16
71
(4268621)
8
31
2.61
1.66
2.5
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
19
3.19
1.66
1.5
2.4
u/ml
514.7
732.9
—
6
19
(40768797) Stomach Pathology biopsy report
64
476
1.41
1.66
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
34
223
1.57
1.63
1.9
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
106
857
1.32
1.62
1.5
1.6
nmol/l
21.6
21.5
0.03
94
714
(3009261) Glucose [Presence] in Urine by Test strip
195
1705
1.26
1.62
4.8
3.8
estimate
0.0
0.0
0.00
43
306
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
88
693
1.34
1.61
2.9
3.0
mmol/l
2.5
2.5
1.77
79
609
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
99
1.85
1.60
2.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
168
1447
1.27
1.57
2.2
2.0
pmol/l
97.3
94.9
0.30
84
721
(3052851) Hemolysis interference index of Serum or Plasma
18
100
1.84
1.55
2.7
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
52
378
1.43
1.54
1.4
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
45
0.00
1.50
0.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
37
2.46
1.48
1.1
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
37
2.46
1.48
1.0
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.45
1.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
22
2.75
1.44
2.2
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
22
2.75
1.44
2.2
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
428
0.65
1.41
15.6
7.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
67
1.97
1.39
1.3
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
280
2579
1.25
1.38
4.3
3.9
pmol/l
15.1
14.8
0.94
260
2306
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
31
210
1.51
1.32
1.5
1.4
—
—
—
0
0
(4035726)
42
304
1.42
1.29
1.3
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
62
1.96
1.29
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
109
911
1.26
1.28
1.9
1.7
mmol/l
1.3
1.3
0.14
94
763
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
85
1.79
1.24
1.5
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
108
1.70
1.24
1.4
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
212
0.55
1.21
1.0
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
316
2969
1.25
1.21
28.4
15.8
%
39.0
39.7
0.68
225
2043
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
317
1.40
1.21
2.8
2.3
u/l
24.8
35.0
1.63
36
262
(3021788) Differential panel - Synovial fluid
13
71
1.86
1.20
2.1
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
64
1.90
1.19
1.4
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
26
2.33
1.19
7.8
3.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
66
1.84
1.10
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
321
3370
0.81
1.09
5.0
4.6
mmol/l
4.8
4.6
1.02
304
3094
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
329
3445
0.80
1.09
5.5
5.2
mmol/l
2.7
2.7
0.09
310
3139
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
21
2.40
1.09
2.4
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
32
2.21
1.08
1.3
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
96
1129
0.81
1.07
3.3
3.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
14
82
1.73
1.06
1.3
5.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
67
1.81
1.05
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
67
1.81
1.05
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
67
1.81
1.05
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
114
1.60
1.04
1.9
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
57
451
1.30
1.04
1.5
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
22
2.29
1.03
2.6
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
236
2174
1.19
1.02
3.7
3.0
u/l
82.1
50.4
1.37
227
2007
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
327
3105
1.23
1.02
5.3
4.7
mu/l
1.9
2.4
0.64
303
2795
(3045788) Cell count panel - Pleural fluid
7
35
2.02
1.00
1.4
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
125
1089
1.21
1.00
4.9
3.9
mg/mmol
4.3
7.7
1.72
84
662
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
308
3236
0.83
0.98
4.3
4.1
mmol/l
1.2
1.3
0.77
284
2931
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
36
1.96
0.97
1.6
2.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
84
706
1.24
0.95
1.8
1.7
nmol/l
1114.1
1210.4
0.60
69
532
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
109
1.58
0.95
1.4
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
37
1.91
0.94
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
110
1.57
0.92
1.4
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
17
111
1.55
0.89
1.2
4.4
mg/l
41.5
127.0
0.80
11
86
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
95
1.60
0.88
1.4
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
56
1.80
0.88
1.8
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
43
1.88
0.87
1.1
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
276
1.33
0.84
3.3
2.7
ml/min/173m2
60.6
62.1
0.13
21
107
(3013512) EKG study
93
1070
0.83
0.82
5.1
3.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
321
3344
0.84
0.82
4.9
4.5
mmol/l
1.6
1.5
6.64
301
3047
(40761535) Cells panel - Urine sediment
37
286
1.32
0.82
6.8
3.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
164
1.43
0.81
1.3
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
48
1.68
0.79
1.1
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
115
1.50
0.78
4.5
2.9
g/l
0.3
0.2
—
5
34
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
59
489
1.24
0.77
1.5
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
34
1.78
0.76
1.5
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.0
—
280.6
—
0
19
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
28
0.00
0.76
0.0
1.0
—
38.6
—
0
18
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.0
—
653.4
—
0
19
(3044290) Cell count panel - Cerebral spinal fluid
9
54
1.68
0.75
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.10
0.74
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
106
934
1.18
0.74
4.0
3.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
25
2.01
0.73
1.2
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
146
1324
1.16
0.71
5.0
4.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
10
61
1.65
0.69
4.3
2.8
mmol/l
105.3
105.8
—
10
61
(3041354) Potassium [Moles/volume] in Venous blood
10
61
1.65
0.69
4.3
2.8
mmol/l
4.0
4.0
—
10
61
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
16
111
1.46
0.67
1.3
4.4
mg/l
26.2
31.8
—
10
87
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
62
1.63
0.65
2.2
2.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
105
1.44
0.61
5.7
5.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
80
1.51
0.60
1.2
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
140
1.37
0.59
1.1
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
60
1.51
0.54
4.7
2.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
97
1075
0.87
0.54
4.7
5.0
ug/l
1.7
2.6
1.67
90
943
(3000330) Specific gravity of Urine by Test strip
24
188
1.29
0.52
4.5
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
330
3198
1.14
0.52
21.3
13.9
ml/min/173m2
76.3
77.4
0.43
301
2633
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15
109
1.39
0.51
1.3
4.3
—
2.5
—
0
12
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
330
3201
1.14
0.50
6.5
6.1
mmol/mol
40.8
40.3
0.40
312
2968
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
48
412
1.19
0.48
2.1
4.2
ug/l
145.8
44.8
0.31
43
347
(3029937) Albumin [Presence] in Urine by Test strip
102
929
1.13
0.47
5.1
4.1
estimate
0.0
0.0
0.50
43
314
(3003434) Protein [Mass/volume] in Pleural fluid
7
48
1.47
0.47
1.3
1.5
g/l
28.9
33.3
—
7
42
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
231
0.77
0.46
2.2
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
31
1.62
0.43
3.6
3.4
—
—
—
0
0
(44806420)
0
16
0.00
0.41
0.0
2.7
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
49.7
—
0
5
(3049717) Cytology report of Urine Cyto stain
18
141
1.29
0.41
2.4
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
335
1.18
0.40
1.8
1.8
%
1.4
1.5
0.20
32
290
(3015183) Erythrocyte sedimentation rate
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
35
1.43
0.39
2.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
35
1.43
0.39
2.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.0
—
1.5
—
0
14
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
80
1.38
0.38
1.7
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
9
67
1.35
0.38
1.0
1.2
e6/l
141.7
5.2
—
9
57
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
67
1.35
0.38
1.0
1.3
e6/l
4485.7
1647.1
—
9
59
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
89
1.36
0.38
1.6
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
179
1.24
0.38
3.5
2.3
%
1.2
1.1
0.15
22
179
(21494755) Public health laboratory ask at order entry panel
20
246
0.80
0.38
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.38
3.3
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
10
72
1.40
0.37
3.0
1.5
iu/l
3.2
6.4
—
5
24
(3024928) Oxygen saturation in Venous blood
9
70
1.29
0.37
2.9
2.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
116
1081
1.10
0.36
3.0
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
328
3352
0.91
0.34
4.8
4.8
mmol/l
5.8
6.0
2.32
307
3039
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
44
1.37
0.34
1.2
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
44
1.37
0.34
7.3
5.6
umol/l
383.8
375.3
—
6
37
(3019150) Specific gravity of Urine by Refractometry
82
758
1.10
0.30
5.4
4.0
kg/l
1.0
1.0
0.97
13
106
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
54
1.30
0.30
2.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
36
318
1.14
0.28
2.9
2.4
ug/l
6.9
7.1
0.04
30
278
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
85
1.30
0.28
2.9
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
55
602
0.90
0.27
2.9
3.0
ug/l
0.7
0.8
0.50
42
391
(4034850)
14
113
1.25
0.27
16.2
9.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
71
0.70
0.26
3.4
1.6
nmol/l
47.2
42.5
—
5
66
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
368
1.13
0.26
4.6
3.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
10
78
1.29
0.24
5.7
2.0
umol/l
24.8
32.5
—
10
61
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
87
818
1.08
0.23
3.3
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
38
1.32
0.23
2.0
2.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
450
0.90
0.22
3.9
4.6
%
35.0
32.4
1.02
33
288
(3019832) Treponema pallidum Ab [Presence] in Serum
17
144
1.19
0.22
2.1
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
165
1591
1.06
0.21
4.9
3.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
10
0.00
0.21
0.0
1.7
—
1.3
—
0
10
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
12
99
1.22
0.20
1.3
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
354
3497
1.07
0.19
22.6
14.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
153
0.84
0.18
2.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
119
1.18
0.18
1.4
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
6
80
0.75
0.15
1.0
1.3
iu/l
41.8
25.9
—
6
69
(3014051) Protein [Presence] in Urine by Test strip
9
79
1.14
0.15
2.8
2.4
—
—
—
0
0
(3019225) pH of Specimen
38
352
1.09
0.15
6.2
3.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
79
755
1.06
0.14
1.7
1.8
pmol/l
410.4
451.1
0.84
69
626
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
846
0.95
0.14
4.2
4.5
%
21.7
21.3
0.11
39
411
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
85
1.18
0.12
1.3
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.1
—
28.6
—
0
8
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
207
0.91
0.09
1.1
1.2
iu/ml
99.9
138.5
—
10
80
(40768806) Pleura Pathology biopsy report
5
47
1.06
0.09
1.4
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
62
0.80
0.08
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
65
0.77
0.08
2.0
1.2
u/l
37.5
10.4
—
5
49
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
88
1.14
0.08
1.5
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
143
0.91
0.07
2.3
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
89
1.13
0.07
1.2
1.7
—
—
—
0
0
(4094501)
8
95
0.84
0.06
1.3
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
20
187
1.07
0.06
2.0
3.1
u/ml
18.7
60.1
1.51
20
181
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
315
0.95
0.06
1.5
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
101
0.89
0.06
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
44
428
1.03
0.04
1.6
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
231
1.04
0.03
5.1
3.0
—
—
—
0
0
(1002224) Polysomnography panel
12
126
0.95
0.00
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
174
1.04
0.00
2.2
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
83
831
1.00
0.00
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
194
0.98
0.00
2.7
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
214
0.98
0.00
1.3
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
162.6
—
0
7
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
12
120
1.00
0.00
2.3
2.0
mg/l
23.3
2.9
0.84
12
89
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
3.9
—
0
7
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.0
—
2322.8
—
0
8
(4133840)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
51.6
—
0
7
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
6.5
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PULMEOS and mortality.

Females

Parameter HR [95% CI] p-value
J10_PULMEOS 1.613 [1.36, 1.91] < 0.001
Birth year 0.994 [0.99, 1.0] 0.183

During the follow-up period (1.1.1998 — 31.12.2019), 276 out of 1053 females with J10_PULMEOS died.

Males

Parameter HR [95% CI] p-value
J10_PULMEOS 1.865 [1.56, 2.23] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 327 out of 857 males with J10_PULMEOS died.

Mortality risk

Mortality risk for people of age

years, who have J10_PULMEOS.

N-year risk Females Males
1 0.16% 0.372%
5 0.928% 2.274%
10 2.312% 5.463%
15 4.365% 9.521%
20 7.696% 15.863%

Relationships between endpoints

↥

Index endpoint: J10_PULMEOS – Pulmonary eosinophilia, not elsewhere classified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data